SHIEF logo

SHIEF Shield Therapeutics plc

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$0.07
+0.00 (+0.00%)

Shield Therapeutics plc operates as a specialized pharmaceutical firm, dedicated to developing and bringing to market advanced clinical therapies that address significant unfulfilled medical requirements. Its flagship product, Accrufer/Feraccru, offers an innovative, non-salt-based oral treatment specifically for adults suffering from iron deficiency, irrespective of whether anemia is present. Fur…

Market Cap: $75.29Mwww.shieldtherapeutics.com

Price

No data yet.

Social Signal Score

40
5d
40
1 mentions
30d
40
1 mentions
60d
40
1 mentions
90d
40
1 mentions
news: 1

Revenue

$28.42M+19860.72%
$-1.90M$8.21M$18.32M$28.42M
Jun 2017Dec 2025

Analyst Estimates

FY2025
$-0.01
$-0.01$-0.01
1 analysts
FY2026
$-0.00
$-0.00$-0.00
1 analysts
FY2027
$0.00
$0.00$0.00
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Anders Lundstrom
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
61
Beta
1.72
Country
GB
Piotroski score
2 / 9 (Weak)
Altman Z-score
-4.76
www.shieldtherapeutics.com